• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of immunologyLink to Publisher's site
Immunology. Nov 1984; 53(3): 575–582.
PMCID: PMC1454908

C3-independent immune haemolysis: haemolysis of EAC14oxy2 cells by C5-C9 without participation of C3.

Abstract

C3-independent immune haemolysis was studied using EAC14oxy2 cells and purified C5, C6, C7, C8 and C9. We have found that EAC14oxy2 cells were lysed by C5-C9 and that haemolysis occurs, even after pretreatment of the cells and the C5-C9 preparation with anti-C3. This indicates that EAC14oxy2 can be lysed by C5-C9 without any participation of C3. In contrast, EAC1 and EAC14 cells are not lysed by C5-C9, suggesting that our C5-C9 preparation lacks activated complement components, such as C3bBb, C5b6 or C(56)a. Based on our study of the haemolysis of EAC14oxy2, we have determined that: (i) EAC14oxy2 cells are lysed by a preparation of C5, C6, C7, C8 and C9, but no lysis occurs when any one of these complement is absent, (ii) for significant haemolysis of EAC14oxy2, a higher concentration of C5 is necessary as compared to the C5 requirement when haemolysis occurs in the presence of C3, (iii) the degree of haemolysis is linearly related to the concentration of C5 and does not reach a plateau, despite the addition of as much as 3,200 U of C5, and (iv) the degree of haemolysis is linearly related to the concentration of cell bound C42. These observations suggest that, in the absence of C3, the C3 convertase C42 can activate C5 directly, resulting in the formation of the membrane attack complex, C5b-9.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (952K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bolotin C, Morris S, Tack B, Prahl J. Purification and structural analysis of the fourth component of human complement. Biochemistry. 1977 May 3;16(9):2008–2015. [PubMed]
  • Hammer CH, Hänsch G, Gresham HD, Shin ML. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a. J Immunol. 1983 Aug;131(2):892–898. [PubMed]
  • Kitamura H, Inai S. Molecular analysis of the reaction of C9 with EAC1-8: reaction of C9 with EAC1-8. J Immunol. 1974 Dec;113(6):1992–2003. [PubMed]
  • Kitamura H, Nagaki K. Inhibitory effect of sugars on the spontaneous lysis of EAC1-8. Mol Immunol. 1981 Nov;18(11):985–990. [PubMed]
  • Kitamura H, Nishimukai H, Sano Y, Nagaki K. Study on C3-like factor in the serum of a C3-deficient subject. Immunology. 1984 Feb;51(2):239–245. [PMC free article] [PubMed]
  • Mayer MM. The complement system. Sci Am. 1973 Nov;229(5):54–66. [PubMed]
  • Nagaki K, Iida K, Okubo M, Inai S. Reaction mechanisms of beta1H globulin. Int Arch Allergy Appl Immunol. 1978;57(3):221–232. [PubMed]
  • Nelson RA, Jr, Jensen J, Gigli I, Tamura N. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry. 1966 Mar;3(2):111–135. [PubMed]
  • Podack ER, Kolb WP, Müller-Eberhard HJ. Purification of the sixth and seventh component of human complement without loss of hemolytic activity. J Immunol. 1976 Feb;116(2):263–269. [PubMed]
  • Polley MJ, Müller-Eberhard HJ. Enharncement of the hemolytic activity of the second component of human complement by oxidation. J Exp Med. 1967 Dec 1;126(6):1013–1025. [PMC free article] [PubMed]
  • Pussell BA, Bourke E, Nayef M, Morris S, Peters DK. Complement deficiency and nephritis. A report of a family. Lancet. 1980 Mar 29;1(8170):675–677. [PubMed]
  • Sano Y, Nishimukai H, Kitamura H, Nagaki K, Inai S, Hamasaki Y, Maruyama I, Igata A. Hereditary deficiency of the third component of complement in two sisters with systemic lupus erythematosus-like symptoms. Arthritis Rheum. 1981 Oct;24(10):1255–1260. [PubMed]
  • Shin HS, Pickering RJ, Mayer MM. The fifth component of the guinea pig complement system. 3. Dissociation and transfer of C5b, and the probable site of C5b fixation. J Immunol. 1971 Feb;106(2):480–493. [PubMed]
  • Tack BF, Morris SC, Prahl JW. Fifth component of human complement: purification from plasma and polypeptide chain structure. Biochemistry. 1979 Apr 17;18(8):1490–1497. [PubMed]
  • Tack BD, Prahl JW. Third component of human complement: purification from plasma and physicochemical characterization. Biochemistry. 1976 Oct 5;15(20):4513–4521. [PubMed]
  • Takahashi M, Takahashi S, Hirose S. Solubilization of antigen-antibody complexes: a new function of complement as a regulator of immune reactions. Prog Allergy. 1980;27:134–166. [PubMed]

Articles from Immunology are provided here courtesy of British Society for Immunology

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...